Medpace Holdings EBIT

Medpace Holdings (MEDP) currently reports a EBIT of $580M as of June 2026. That compares with $490M in the prior-year period — up 18.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Medpace Holdings's EBIT history and peer comparisons.

Medpace Holdings's EBIT increased from $490M to $580M — a 18.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Medpace Holdings's EBIT of $580M is lower than the Healthcare sector average of $23B. That is roughly 97.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Medpace Holdings reported $580M in EBIT as of June 2026. That compares with $490M in the prior-year period — up 18.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $580M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Medpace Holdings, and consider following MEDP for alerts when major investors trade the stock.